HOME >> MEDICINE >> NEWS
Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer

CHICAGO, June 2, 2007 -- ALIMTA (pemetrexed for injection) showed additional utility in the treatment of the most diagnosed type of cancer , according to data presented today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO). Results from a Phase III study suggest that a first-line ALIMTA-based regimen may deliver less toxicity than a commonly used therapy in advanced non-small cell lung cancer (NSCLC). ALIMTA is manufactured and marketed by Eli Lilly and Company.

A prospective, randomized, multicenter Phase III study was conducted to compare ALIMTA plus carboplatin with the commonly used regimen of GEMZAR (gemcitabine HC1 for injection) plus carboplatin (ASCO Abstract # 7517 ). The study, conducted by the Norwegian Lung Cancer Group, enrolled 446 chemonave patients with either stage IIIB or IV NSCLC. The primary purpose of the study was to evaluate if the ALIMTA-carboplatin combination provided increased quality-of-life benefits while offering comparable survival data. As such, the primary endpoint was quality of life (defined in the study as nausea/vomiting; dyspnea or a difficulty in breathing, and; fatigue) and the secondary endpoint was overall survival.

Thus far, 384 patients have been analyzed for toxicity and there were fewer patients in the ALIMTA arm who experienced Grade 3/4 thrombocytopenia or a low platelet level (48 vs. 107, p<.001); leukopenia or a lowering of leukocyte white blood cells (44 vs. 89, p<.001), and; granulocytopenia or a lowering of granulocyte white blood cells (78 vs. 98, p=.02). More patients in the GEMZAR arm received transfusion of platelets (5 vs. 19, p=.02). At this point, no difference in survival has been observed.

The patients in this study received a comparable quality-of-life benefit whether they received ALIMTA and carboplatin or GEMZAR and carboplatin, said Bjrn Henning Grnberg, M.D. of St. Olavs University Hospital in Norway and the studys principal investigat
'"/>

Contact: Neil Hochman
n.hochman@cprworldwideusa.com
212-453-2067
CPR Worldwide
2-Jun-2007


Page: 1 2 3

Related medicine news :

1. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
2. Clinical review -- A psychological approach to the management of irritable bowel syndrome
3. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
4. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
5. Clinical guidelines for blood conservation during cardiac procedures developed
6. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
7. Clinical trial coordinators need more financial conflict-of-interest training
8. Clinical studies evaluate potential treatments for mouth ulcers
9. NIH names Clinical Trial Units for the Microbicide Trials Network
10. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
11. Study in recent issue of Clinical Pediatrics helps pediatricians to understand discipline practices

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... 08, 2019 , ... In Vitro Sciences (IVS), a prominent ... (AFC), an advanced reproductive services (RE) facility operating in the greater Phoenix area. ... to expectant families throughout Arizona and the greater Southwest. , This partnership between ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... and support services for the Department of Veterans Affairs Community Care Referrals and ... its implementation of the VA’s Health Share Referral Manager (HSRM), an enterprise-wide system ...
(Date:10/8/2019)... PARK, Md. (PRWEB) , ... October 08, 2019 ... ... observe fungal infection progression in live samples, Meiqing Shi, associate professor with the ... the field. In his latest paper published in Nature Communications, Shi and his ...
(Date:10/8/2019)... ... ... Over the past three decades, Buffalo Wings & Rings has elevated the chicken ... a higher-quality product and experience than the competition. Now, the club-level sports restaurant brand ... FOR THE CAUSE" campaign in support of Breast Cancer Awareness Month. , “We ...
(Date:10/8/2019)... ... October 08, 2019 , ... METAvivor Research and Support Inc., a non-profit ... of its Stage IV Stampede campaign. The campaign will commence with two days of ... include an advocacy boot camp, a march, a Die-In (hosted by partner MET-UP), and ...
Breaking Medicine News(10 mins):
(Date:10/11/2019)... ... October 11, 2019 , ... MindShare Technology Founder and CEO ... the 2019 Alliance for Strong Families and Communities National Conference. The conference is at ... 2019 from 3:30 – 5:00 p.m. , Povolny’s presentation will provide real world ...
(Date:10/10/2019)... ... October 10, 2019 , ... Smile Brands Inc. together with its affiliate A+ ... opening of a new A+ location in Natomas. , A+ Dental Care (“A+”) is ... The group’s 14 general dentists and three specialists work together as a team to ...
(Date:10/8/2019)... , ... October 09, 2019 , ... “When Seconds Count: ... frustrations, and the realities of the HEMS world through telling the real stories of ... is the creation of published author Jay A. Humphrey, an EMS helicopter pilot. He ...
Breaking Medicine Technology:
Cached News: